miR-148-3p inhibits gastric cancer cell malignant phenotypes and chemotherapy resistance by targeting Bcl2-Reference-Cited by-同舟云学术

miR-148-3p inhibits gastric cancer cell malignant phenotypes and chemotherapy resistance by targeting Bcl2

Published:2021-11-16 Issue: Volume: Page:
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zhang Hongyan¹,Liang Feng²,Wang Fei¹,Xu Qianru²,Qiu Yuxuan²,Lu Xin²,Jiang Lin²,Jian Kaiyu²

Affiliation:

1. Department of Oncology, The Seventh Medical Center of PLA General Hospital, Beijing, China; 100700

2. Department of General Surgery, The Seventh Medical Center of PLA General Hospital, Beijing, China; 100700

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2005742

Reference41 articles.

1. [1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries. CA Cancer J Clin. 2018; 68(6): 394-424.

2. [2] GBD Stomach Cancer Collaborators, The global, regional, national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017, Lancet Gastroenterol. Hepatol. 2020; 5: 42e54.

3. [3] W Zhang, X Ding, H Cheng, CY Yin. Dual-targeted gold nanoprism for recognition of early apoptosis, dual-model imaging and precise cancer photothermal therapy, Theragnostic. 2019; 9: 5610e5625.

4. [4] Ham IH, Oh HJ, Jin H, Bae CA, Jeon SM, Choi KS, Son SY, Han SU, Brekken RA, Lee D, Hur H. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol Cancer. 2019; 18(1): 68.

5. [5] S Wang, Z. Chen, S Zhu, H Lu. PRDX2 protects against oxidative stress

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statement of Retraction: miR-148-3p inhibits gastric cancer cell malignant phenotypes and chemotherapy resistance by targeting Bcl2;Bioengineered;2024-02

2. LncRNA H19 Promotes Gastric Cancer Metastasis via miR‐148‐3p/SOX‐12 Axis;Analytical Cellular Pathology;2024-01

3. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response;Biomedicine & Pharmacotherapy;2022-12

4. Circular_0086414 induces SPARC like 1 (SPARCL1) production to inhibit esophageal cancer cell proliferation, invasion and glycolysis and induce cell apoptosis by sponging miR-1290;Bioengineered;2022-05-02